Legal provisions of COM(2006)616 - For duty-free treatment for specified pharmaceutical active ingredients bearing an "international non-proprietary name" (INN) from the World Health Organisation and specified products used for the manufacture of finished pharmaceuticals and amending Annex I to Regulation (EEC) No 2658/87

Please note

This page contains a limited version of this dossier in the EU Monitor.

dossier COM(2006)616 - For duty-free treatment for specified pharmaceutical active ingredients bearing an "international non-proprietary name" ...
document COM(2006)616 EN
date February 12, 2007


Article 1

As from 1 January 2007 the Community shall extend duty-free treatment to the INNs listed in Annex I.

Article 2

As from 1 January 2007 the list of prefixes and suffixes which, in combination with the INNs, describe the salts, esters or hydrates of INNs which are also eligible for duty-free treatment, on condition that they are classifiable in the same six-digit HS-subheading as the corresponding INN, shall be replaced by the list in Annex II.

Article 3

As from 1 January 2007 the Community shall extend duty-free treatment to the intermediates used in the production and manufacture of pharmaceutical products listed in Annex III.

Article 4

As from 1 January 2007 the intermediates listed in Annex IV shall no longer benefit from duty-free treatment.

Article 5

Annexes 3, 4 and 6 of Section II of Part three of Annex I to Regulation (EEC) No 2658/87 (Lists of pharmaceutical substances which qualify for duty-free treatment) shall be amended accordingly.

Article 6

This Regulation shall enter into force on the day following its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.